GlobalOptions Group, Inc. GLOI today announced results for the second quarter ended June 30, 2010.
Revenue for the second quarter of 2010 was $6.5 million compared to $5.4 million for the same period in 2009. Operating income for the company's Forensic DNA Solutions and Products unit grew by 39% to $0.7 million, compared to $0.5 million for the second quarter last year.
The operating loss for the second quarter of 2010 was $2.8 million, compared to an operating loss of $2.4 million for the second quarter of last year. Included in the operating loss for the second quarter of 2010 is approximately $1.1 million of professional fees associated with the company's review of strategic and financial alternatives and various sales transactions completed and/or negotiated during the quarter.
EBITDA from continuing operations for the second quarter of 2010 was $(2.4) million compared to $(2.1) million last year, and EBITDAS (EBITDA before stock based compensation) from continuing operations was $(2.0) million, compared to $(1.3) million last year.
GlobalOptions Group's loss from continuing operations for the second quarter of 2010 was $3.0 million, compared to a loss from continuing operations of $2.6 million for the second quarter of 2009. After factoring in results from discontinued operations, net loss for the second quarter of 2010 was $8.1 million, or $0.58 per share, compared to net losses of $0.8 million, or $0.06 per share, for the second quarter of 2009.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in